Waters Corporation
NYSE:WATMedical - Diagnostics & Research
-$0.57 today
- Market cap
- $45.81B
- Beta
- 1.20
- P/E (TTM)
- 65.2
- EPS (TTM)
- $5.47
Volume 0.73M
Average 1.03M
WAT Operating Cash Flow
Cash generated by the company's core business operations during the period.
Waters CorporationNYSE: WAT
Operating Cash Flow · Q2 FY2026 · quarter ended Jul 2026
Operating cash flow growth accelerates
Q2 FY2026 operating cash flow of $201M rose 388.6% year over year, ahead of the -26.2% change in trailing-twelve-month operating cash flow. Over 3 fiscal years it compounded at +2.2% a year.
Context
- Operating cash flow amounted to 20.6% of revenue in FY2025, down 5.1 pp from a year earlier.
- Operating cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +388.6% holds above the trailing-twelve-month pace of -26.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 652.56M USD
- Year-over-year change
- -14.4%
- 4-year CAGR
- -3.3%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 652.56M | -14.4% |
| FY2024 | 2024-12-31 | 762.12M | +26.4% |
| FY2023 | 2023-12-31 | 602.81M | -1.4% |
| FY2022 | 2022-12-31 | 611.66M | -18.1% |
| FY2021 | 2021-12-31 | 747.27M | — |
Operating Cash Flow vs competitors
How WAT compares with its peers on the latest reported figures
- WAT's LTM Jul 2026 operating cash flow of $549.86M is the 6th largest of the 7 companies compared; the peer median is $1.29B.
- Its year-over-year change of -26.2% is the lowest of 7, against a peer median of +8.1%.
- Operating cash flow amounts to 11.8% of revenue for WAT, versus a peer median of 21.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $9.32B | +21.9% | -5.1% | 19.7% | |
| LTM Sep 2026 | $6.86B | +8.6% | -9.0% | 26.8% | |
| LTM Jul 2026 | $1.61B | +7.6% | +5.9% | 21.8% | |
| LTM Jun 2026 | $975.17M | +2.5% | +3.6% | 23.6% | |
| LTM Jul 2026 | $628.86M | +7.6% | -5.1% | 21.6% | |
| LTM Jul 2026 | $549.86M | -26.2% | +2.2% | 11.8% | |
| LTM Jun 2026 | $190.4M | +14.8% | -21.2% | 5.4% | |
| Peer median (excluding WAT) | $1.29B | +8.1% | -5.1% | 21.7% | |
Competitors are the stored peer set for WAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 692.84M | 707.76M | 642.23M | 637.83M | 642.63M |
| Depreciation & Amortization | 131.68M | 130.42M | 165.91M | 191.83M | 206.24M |
| Deferred Income Tax | 16.63M | (31.99M) | (1.2M) | (877K) | (14.66M) |
| Stock-Based Compensation | 29.92M | 42.56M | 36.87M | 44.71M | 54.13M |
| Change in Working Capital | (107.17M) | (269.08M) | (240.26M) | (111.37M) | (233.38M) |
| Accounts Receivables | (62.45M) | (137.87M) | 49.18M | (66.24M) | (55.5M) |
| Inventory | (67.25M) | (101.9M) | (45.44M) | 20.94M | (65.93M) |
| Accounts Payables | 46.11M | 60.98M | (79.52M) | 61.59M | (89.01M) |
| Other Working Capital | (23.58M) | (90.29M) | (164.47M) | (127.66M) | (22.94M) |
| Other Non-Cash Items | (16.63M) | 31.99M | (742K) | 0 | (2.4M) |
| Operating Cash Flow | 747.27M | 611.66M | 602.81M | 762.12M | 652.56M |
| Capital Expenditures | (168.27M) | (183.46M) | (160.63M) | (142.48M) | (112.75M) |
| Acquisitions (Net) | 7M | (1.37M) | (1.28B) | (1.49M) | (35.05M) |
| Purchases of Investments | (63.36M) | (11.41M) | (1.79M) | (3.73M) | (7.3M) |
| Sales of Investments | 218.08M | 86.9M | 2.51M | 3.68M | 0 |
| Other Investing Activities | (225.08M) | 1.37M | 0 | 0 | 2.84M |
| Investing Cash Flow | (231.63M) | (107.97M) | (1.44B) | (144.02M) | (152.25M) |
| Debt Repayment | 160M | 60M | 780M | (730M) | (243.32M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 20.79M |
| Common Stock Repurchased | (648.93M) | (626.06M) | (70.28M) | (13.54M) | (14.67M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 50.66M | 56.43M | 45.23M | 46.87M | (7K) |
| Financing Cash Flow | (438.28M) | (509.63M) | 754.95M | (696.68M) | (237.21M) |
| Effect of Forex Changes | (12.83M) | (14.77M) | (948K) | 7.92M | (621K) |
| Net Change in Cash | 64.54M | (20.71M) | (85.45M) | (70.66M) | 262.48M |
| Free Cash Flow | 579.01M | 428.21M | 442.18M | 619.64M | 539.81M |
Waters Corporation
NYSE:WAT
Intrinsic Alpha fair value
Locked
Current Price
$466.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.